$MRNA breakout paused by selloff on speculation of Ph3 trial delay / protocol changes. With detailed but not peer reviewed $INO $PFE $BNTX data out, all eyes on upcoming  #moderna_tx peer reviewed Ph1 publication, taking of advantage competitors' published early results $Ibb $xlv https://t.co/IHjUC4KD9b